This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Selected Drugs Clear All

MultiCheck Results - 8 Interactions

Avoid/Use Alternative
Apri (desogestrel/ ethinyl estradiol) + Covaryx (estrogens, esterified/ methyltestosterone)
Avoid/Use Alternative ethinyl estradiol (contraceptive) + estrogens, esterified (hormone replacement) avoid combo: combo may incr. risk of thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy) Monitor/Modify Tx desogestrel (contraceptive) + estrogens, esterified (hormone replacement) monitor thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects) desogestrel (contraceptive) + methyltestosterone monitor thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects) ethinyl estradiol (contraceptive) + methyltestosterone monitor BP, thrombosis s/sx: combo may incr. risk of HTN, thromboembolism (additive effects)
Monitor/Modify Tx
Apri (desogestrel/ ethinyl estradiol) + Prandin (repaglinide)
Monitor/Modify Tx desogestrel (contraceptive) + repaglinide monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) ethinyl estradiol (contraceptive) + repaglinide monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Covaryx (estrogens, esterified/ methyltestosterone) + Prandin (repaglinide)
Monitor/Modify Tx estrogens, esterified (hormone replacement) + repaglinide monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) methyltestosterone + repaglinide monitor glucose: combo may incr. risk of hypoglycemia (additive effects)